Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 2/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.32 |
| ▸ | BUB1 | O43683 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4698979 | 0.74 | NR1H2 (0.36) | — | |
| SCHEMBL21244820 | 0.72 | BUB1 (0.40) | DDB1CRBNBUB1 | |
| SCHEMBL26915659 | 0.72 | GRIN2B (0.38) | DDB1CRBNBUB1 | |
| SCHEMBL28036996 | 0.72 | — | — | |
| SCHEMBL751694 | 0.71 | BUB1 (0.35) | DDB1CRBNBUB1 | |
| SCHEMBL25301908 | 0.69 | BUB1 (0.38) | DDB1CRBNBUB1 | |
| SCHEMBL350967 | 0.69 | BUB1 (0.38) | DDB1CRBNBUB1 | |
| SCHEMBL31456782 | 0.69 | BUB1 (0.38) | DDB1CRBNBUB1 | |
| SCHEMBL17937395 | 0.67 | BUB1 (0.36) | DDB1CRBNBUB1 | |
| SCHEMBL26915679 | 0.67 | BUB1 (0.36) | DDB1CRBNBUB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216374-A1 | Antibiotic oxazolidinone derivatives | SYNGENTA LIMITED (GB) | 2003-11-20 | — | — | US | disclosed |
| US-6605630-B1 | Active against drug resistant gram positive pathogens | SYNGENTA LIMITED (GB) | 2003-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216374-A1 | Antibiotic oxazolidinone derivatives | OXA1L, HRH1, OGDH | DDB1 2801/4885CRBN 1203/4885BUB1 1312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.